Uplisting to AMEX at Year End Analysis... The answer to

New Post Public Reply Private Reply Replies (2) Message Board
Wilma6311 Vulcan classic #3261
Uplisting to AMEX at Year End Analysis...

The answer to whether a RS will be needed if they want to uplist by year end is 100% due to the share price. The higher the share price the less the RS and if the share price is $2 we won't need it at all.

Below is an analysis of what Standard would be used to uplist to AMEX and the worst case scenario for a RS and if they just went back to 500mil AS which they have done a couple times. Like I said...if the share price is $2 they won't need one at all.

DEFINITIONS:
Public float - refers to shares of stock owned by the public and not by company directors, officers or controlling interest investors.

Shareholder equity
- is the net worth of the company--that is, the difference between assets and liabilities.

Market capitalization - refers to the market price of the entire company. This is calculated by multiplying the number of shares in investor hands by the market price of the stock.

CURRENT:

Shares in public hands (non-director) – 1,875,000,000
Current Share Price - $.0016
Public Float – 1.875 * .0016 = 3mil
SH Equity – currently negative (appx 5mil for 2015)
Market Cap – 12.5bil * .0016 = 20mil

If they want to uplist by EOY then they won’t meet #1 and #2 below which requires 2 years of financials.

Standard 3 is the most likely option in that case. Unless the share price is $2 by YE they would need to do a RS. I calculated the worst case scenario below that would be needed to meet the 15mil public float at $2 per share - The shares in non-director hands would need to be at least 7.5mil. (15mil / 2 per share). I also calculated the scenario which puts them back to 500mil in AS which is a number they have gone back to a couple times in the past. But as I said…if the pps is $2 they won’t need a RS at all.

Standard 1 – Needs two years of operations

$750,000 in pre-tax income in the two most recent fiscal years
The minimum price of its stock must be $3
Public float must have a market value of $3 million
Shareholder equity must be at least $4 million.


Standard 2 – Needs two years of operations

Company must have a stock price of at least $3.
The company does not have to meet income requirements.
Public float must be at least $15 million
Shareholder equity must be at least $4 million
AMEX requires companies to provide at least two years of operating history.
_______________________________________________________

Standard 3 – Most likely scenario

Meet a minimum of $50 million in market capitalization.
Meet a minimum $15 million market value public float
A Minimum of $4 million in shareholder equity.
Share price must be at least $2.

This option would be most likely if they don’t have two years of operations and two years of profits as in #1 and #2 above.

The biggest challenge in uplisting will be shareholders equity which is Assets less Liab and is currently negative for both companies and needs to be $4mil. That would mean they would have to increase assets and decrease liabilities but that profits would be needed to do this as well in order to increase cash.

***Depending on the share price at year end I calculated a few options for a RS below.

NO RS - IF SHARE PRICE WAS $2 with Current SS
Shares in public hands (non-director) – 1,875,000,000
Current Share Price - $2
Public Float – 1.875 * $2 = $3.75bil (250 times higher than needed for Standard 3)
SH Equity – currently negative (appx 5mil for 2015) – Would need to be 4mil
Market Cap – 12.5bil * $2 = $25bil (500 times higher than needed for Standard 3)

**Worst Case Scenario - If the share price at YE was only .008, they could RS 1:250 to reach $2 per share.

**WITH A 1:250 RS (57,500,000 AS) WORST CASE SCENARIO to meet public float at $2 per share

Shares in public hands (non-director) – 7,500,000
Current Share Price - $2
Public Float – 7.5mil * $2 = 15mil
SH Equity – currently negative (appx 5mil for 2015)
Market Cap – 50mil * $2 = 100mil

WITH A 1:25 RS (500,000,000 AS) I used this AS because they have RS back to this number a couple of times in the past. The current share price would need to be 8 cents
Shares in public hands (non-director) – 75,000,000
Current Share Price - $2 (Would need to be orig .08 or 8 cents)
Public Float – 75mil * $2 = 150mil
SH Equity – currently negative (appx 5mil for 2015)
Market Cap – 425mil * $2 = 850mil
_______________________________________________________

Standard 4 – The revenue requirement is too high here

Either have $75 million in market capitalization or
At least $75 million in revenue and $75 million in assets
Public float must have a minimum value of $20 million
Share price of at least $2.

Talkspace Inc. (TALK) Stock Research Links

TALK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leqembi Pen Revolutionizes Alzheimer's Care in Japan

Updated Category News Views 22

Innovative Alzheimer's Treatment Hits Japanese Market Just when you think the medical world needs a jolt of innovation, BioArctic rolls out something that could change how Alzheimer's is managed. With their subcutaneous Leqembi Pen, they've just added another feather in their cap, launching in Japan after a successful U.S. introduction. Not just your run-of-the-mill...

Continue Reading
Randi Baptiste Sets a New Standard in Youth Sports

Updated Category News Views 62

Youth Sports: Revolutionized by Randi Baptiste In an era where youth sports face a minefield of health risks and performance pressures, Randi Baptiste stands out. This isn't just about running around the park—this is about fundamentally transforming how we think about athletic development for young folks. Recognizing Baptiste for his contributions, The Inner Circle...

Continue Reading
Simform's AI Innovations Earns Microsoft Award Nod

Updated Category News Views 64

Riding the AI Wave with Simform In the chaotic world of AI and tech partnerships, earning recognition from a powerhouse like Microsoft ain't your run-of-the-mill achievement. Simform being recognized as a finalist for the 2026 Microsoft Innovate with Azure AI Apps and Agents Partner of the Year Award is a big deal, not just for them, but as a beacon of inspiration for...

Continue Reading
GAC's Green Push Unveils 3rd Showroom in Casablanca

Updated Category News Views 146

Pushing Through North Africa's Automotive Shift Well, looks like GAC is showing they're not just dabbling in North Africa—they're planting some sturdy roots in that rocky soil. Opening their third showroom in Casablanca, GAC isn't just settling for sidelines. They're step-in-the-ring serious about carving their name on North African roads. This isn't some skin-deep...

Continue Reading
Adam Foundation's Ramadan Effort to Cut Plastic Waste

Updated Category News Views 27

Environmental Consciousness: A Call from Antalya Here we go again, folks. Something refreshing is brewing over in Antalya at COP31, where the UK-based Adam Foundation has made a move that resonates beyond the usual hubbub. No smoke and mirrors, just straightforward action aimed at cutting down the wave of plastic waste during Ramadan. This isn't some pie-in-the-sky green...

Continue Reading
FF EAI Robotics Aims for Top Spot in K-12 Tech

Updated Category News Views 28

FFR's Shot at Robotics Education Dominance You ever feel like a company is throwing everything but the kitchen sink at an opportunity? That's FF EAI Robotics for you—charging ahead with a hefty laundry list of tech ambitions. They've clocked in about $2.3 million in revenue from their newly acquired robotics wing for the first nine months of 2026, showing a 26% gross...

Continue Reading
Rethinking Risk: AI, Cyber, and Ops Convergence

Updated Category News Views 28

Risk Management's New Frontier Hold onto your hats, folks, because the landscape of risk management is shifting under our feet—and not a minute too soon. With AI adoption skyrocketing, cybersecurity threats piling up like never-ending junk mail, and operational hurdles lurking around every corner, Wipfli's throwing down the gauntlet for business leaders to wise up....

Continue Reading
Implantica's Q3 2026: A Potential Leap Forward?

Updated Category News Views 34

Implantica Prepares to Unveil Q3 Results We're heading into the home stretch for 2026, and Implantica's about to unveil its third-quarter results. With its presentation scheduled for November 19 at 15:00 CET, this medtech outfit has caught some eyes, especially with their flagship offering, RefluxStop®. Paying attention here might be worthwhile, as this plays into a...

Continue Reading
Squeez and Qentelli Join Forces to Revolutionize Loyalty

Updated Category News Views 438

A New Era of Loyalty Commerce The winds are changing in the loyalty game, and it's about time someone shook things up. Squeez has teamed up with Qentelli, thanks to a $1 million investment, to kick-start this next wave of commerce. And boy, it's not just about money—it's like combining brains with brawn. Squeez isn't just offering loyalty programs anymore; they're...

Continue Reading
Vipshop Sets 2026 AGM: Shareholders Meet on Dec 8

Updated Category News Views 21

Blockbuster or Bust: Vipshop's Upcoming AGM Here's the scoop: Vipshop Holdings Limited, with its mammoth operations in China's off-price retail sector, is gearing up for its annual general meeting (AGM) on December 8, 2026. This is where management and stakeholders will hash out everything from strategic pivots to financial health. Forget shareholder votes this...

Continue Reading

Top 5 Most Recently Viewed Articles

Actinium Pharmaceuticals Faces Class Action Lawsuit for Losses

Updated Category News Views 198

Actinium Pharmaceuticals: A Closer Look at the Lawsuit Recently, a significant class action lawsuit was filed against Actinium Pharmaceuticals, Inc. (NYSE: ATNM). This legal action is vital for investors who have experienced financial losses associated with their investments in Actinium's stock. The lawsuit, initiated by Pomerantz LLP, accuses the company and some of its...

Continue Reading
Uranium Energy Corp Delivers Promising Drill Results at Roughrider

Updated Category News Views 69

Uranium Energy Corp Unveils Outstanding Drilling Results Uranium Energy Corp (NYSE American: UEC) is thrilled to share the latest findings from its active drilling campaign at the Roughrider Project, which have revealed striking high-grade uranium mineralization. A drill hole positioned 850 meters northeast of the central Roughrider deposit has showcased remarkable...

Continue Reading
TME Pharma Presents Promising Glioblastoma Trial Outcomes

Updated Category News Views 159

TME Pharma's Progress in Glioblastoma Treatment TME Pharma N.V. is a clinical-stage biotechnology company dedicated to developing innovative therapies for cancer. Recently, they announced an important oral presentation at a renowned medical congress, showcasing the encouraging results from the NOX-A12 GLORIA Phase 1/2 trial. This study aims to address glioblastoma, a...

Continue Reading
Life Time Champions Expanding Pickleball Facilities Across U.S.

Updated Category News Views 327

Life Time Champions Expanding Pickleball Facilities Across U.S. Life Time (NYSE: LTH) proudly marks World Pickleball Day as the sport continues to gain unprecedented popularity across America. With over 750 permanent pickleball courts established within its athletic country clubs, the organization demonstrates its commitment to being at the forefront of this dynamic...

Continue Reading
Edgewise Therapeutics Shares Breakthrough EDG-7500 Results

Updated Category News Views 305

Edgewise Therapeutics Announces Significant Progress in Hypertrophic Cardiomyopathy Treatment Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a pioneering biopharmaceutical company focused on muscle diseases, has recently disclosed positive outcomes from their Phase 2 CIRRUS-HCM trial studying EDG-7500. This treatment targets hypertrophic cardiomyopathy (HCM), a serious...

Continue Reading